Early and late inflammatory bowel disease: Why and how are they different?

Current Opinion in Gastroenterology

Volumn 27, Issue 4, 2011, Pages 317-320

  Fiocchi, Claudio ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CELL DIFFERENTIATION; CROHN DISEASE; DISEASE COURSE; DISEASE MODEL; EARLY DIAGNOSIS; EDITORIAL; ENTERITIS; EPIGENETICS; GENE INTERACTION; GENOME; HELPER CELL; HUMAN; IMMUNE MEDIATED INJURY; IMMUNE SYSTEM; MICROBIOME; NEUROENDOCRINE SYSTEM; NONHUMAN; ONSET AGE; PATHOGENESIS; SYMPTOM; ULCERATIVE COLITIS;

DISEASE PROGRESSION; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 79958830721     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283483986     Document Type: Editorial

References (14)

1. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4:553-564. (Pubitemid 38931770)
2. Rappaport SM, Smith MT. Epidemiology. Environment and disease risks. Science 2010; 330:460-461.
3. Favier CF, Vaughan EE, DeVos WM, Akkermans ADL. Molecular monitoring of succession of bacteria communities in human neonates. Appl Environ Microbiol 2002; 68:219-226. (Pubitemid 34031183)
4. Xavier RJ, Rioux JD. Genome-wide association studies: a new window into immune-mediated diseases. Nat Rev Immunol 2008; 8:631-643.
5. Sauer CG, Kugathasan S. Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. Med Clin North Am 2010; 94: 35-52.
6. Kugathasan S, Saubermann LJ, Smith L, et al. Mucosal T-cell immunoregulation varies in early and late Crohn's disease. Gut 2007; 56:1696-1705. (Pubitemid 350206296)
7. O'Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010; 327:1098-1102.
8. Kaser A, Zeissing S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010; 28:573-621.
9. Wilson AG. Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol 2008; 79:1514-1519.
10. Spencer DM, Veldman GM, Banerjee S, et al. Distinct inflammatorymechanisms mediate early versus late colitis in mice. Gastroenterology 2002; 122:94-105. (Pubitemid 34049199)
11. Bamias G, Martin C, Mishina M, et al. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 2005; 128:654-666. (Pubitemid 40585368)
12. Kugathasan S, Werlin SL, Martinez A, et al. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. Am J Gastroenterol 2000; 95:3189-3194.
13. D'Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008; 371:660-667. (Pubitemid 351284485)
14. Fiocchi C. Future of IBD pathogenesis: how much work is left to do? Inflamm Bowel Dis 2008; 14 (Suppl 2):S145-S147.